Currently, Neumora Therapeutics Inc [NMRA] is trading at $0.75, up 4.41%. It is a good measure of the stock’s recent performance to check whether the stock’s short-term value is rising or falling. The NMRA shares have gain 10.03% over the last week, with a monthly amount drifted -3.05%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Neumora Therapeutics Inc [NASDAQ: NMRA] stock has seen the most recent analyst activity on April 02, 2025, when BofA Securities downgraded its rating to a Underperform but kept the price target unchanged to $1 for it. Previously, William Blair downgraded its rating to Mkt Perform on March 10, 2025. On March 07, 2025, downgrade downgraded it’s rating to Hold and revised its price target to $2 on the stock. Guggenheim downgraded its rating to a Neutral. RBC Capital Mkts downgraded its rating to a Sector Perform and reduced its price target to $4 on January 02, 2025. JP Morgan downgraded its rating to Neutral for this stock on November 05, 2024, and downed its price target to $15. In a note dated October 01, 2024, H.C. Wainwright initiated an Buy rating and provided a target price of $30 on this stock.
This stock has fluctuated between a low of $0.61 and a high of $17.19 over the last 52 weeks. Currently, Wall Street analysts expect the stock to reach $3 within the next 12 months. Neumora Therapeutics Inc [NASDAQ: NMRA] shares were valued at $0.75 at the most recent close of the market. An investor can expect a potential return of 300.0% based on the average NMRA price forecast.
Analyzing the NMRA fundamentals
To continue investigating profitability, this company’s Return on Assets is posted at -1.01, Equity is -0.85 and Total Capital is -1.2. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.0.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 0.7092 points at the first support level, and at 0.6704 for the second support level. However, for the 1st resistance point, the stock is sitting at 0.7675, and for the 2nd resistance point, it is at 0.7870.
Ratios To Look Out For
To put it in perspective, the Current Ratio for Neumora Therapeutics Inc [NASDAQ:NMRA] is 8.98. Further, the Quick Ratio stands at 8.98, while the Cash Ratio is 4.47.
Transactions by insiders
Recent insider trading involved Henry Gosebruch, Officer, that happened on Mar 12 ’25 when 15000.0 shares were purchased., BERNS PAUL L completed a deal on Feb 18 ’25 to sell 13871.0 shares. Meanwhile, Milligan Michael Lee sold 1978.0 shares on Feb 18 ’25.
